Anonymous wrote:These two fatties have made it through to the other side of Covid. Now I am wondering, have things changed regarding the serious outcomes? Where are the Washington Post stories of the outlier marathon runners who are near death? Is it truly less lethal? Or has the media just just moved on to other things?

Anonymous wrote:

Anonymous wrote:

Anonymous wrote:

Anonymous wrote:They get health care at Walter Reed with VIP doctors that the rest of us at Walter Reed cannot get. Many of us cannot even get anything beyond basic primary care, forget specialists. Walter Reed has doctors working on the virus and a vaccine and they have doctors who go between Walter Reed and NIH.

Christie was treated at a regular hospital in NJ.

That hospital is actually in my town and it has many specialized departments, including a critical care unit for respiratory illnesses. People come from other parts of NJ, as well as from PA to go there for treatment for all sorts of conditions.

Sure, but lots of regular people who need specialized care go there. There is no comparison between that and Walter Reed.

Anonymous wrote:I don’t think we have gotten anything like an accurate story about COVID. The media went crazy sensationalizing and leaving out key facts. Holding up one person to represent thousands. Meanwhile many many people had mild version and it was never reported. It is a vicious disease for some that part is true but who and how many still remains a mystery.

Anonymous wrote:

Anonymous wrote:It’s not just about lethality (and low death rates depend on not having an overwhelming number of people need ICU care at the same time).

A friend of mine, 30s, very fit and athletic, got Covid 12 weeks ago. She was hospitalized 6 days and very nearly vented. She now permanently has asthma and is very fatigued at all times, barely walking let alone running or working out. It’s been 12 weeks. She is nowhere near normal health. And show me the statistics that track that?!?

I am very sorry about your friend. Everybody knows “somebody” but yet so many people have survived or had a truly mild case. Most people I know personally.

Anonymous wrote:It’s not just about lethality (and low death rates depend on not having an overwhelming number of people need ICU care at the same time).

A friend of mine, 30s, very fit and athletic, got Covid 12 weeks ago. She was hospitalized 6 days and very nearly vented. She now permanently has asthma and is very fatigued at all times, barely walking let alone running or working out. It’s been 12 weeks. She is nowhere near normal health. And show me the statistics that track that?!?

Anonymous wrote:

Anonymous wrote:I do wonder about the impact of viral loads. Early on, the effects seemed more horrific.

Shhhhh. This will be covered by the media AFTER the election.

Anonymous wrote:These two fatties have made it through to the other side of Covid. Now I am wondering, have things changed regarding the serious outcomes? Where are the Washington Post stories of the outlier marathon runners who are near death? Is it truly less lethal? Or has the media just just moved on to other things?

Anonymous wrote:to the Doubters and Trump Haters.... THIS HHS press release was but a blip news story several months ago...

FOR IMMEDIATE RELEASE
June 29, 2020

Trump Administration Secures New Supplies of Remdesivir for the United States

On Monday, the Department of Health and Human Services announced an agreement to secure large supplies of the drug remdesivir for the United States from Gilead Sciences through September, allowing American hospitals to purchase the drug in amounts allocated by HHS and state health departments.

“President Trump has struck an amazing deal to ensure Americans have access to the first authorized therapeutic for COVID-19,” said HHS Secretary Alex Azar. “To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump Administration is doing everything in our power to learn more about life-saving therapeutics for COVID-19 and secure access to these options for the American people.”

HHS has secured more than 500,000 treatment courses of the drug for American hospitals through September. This represents 100 percent of Gilead’s projected production for July (94,200 treatment courses), 90 percent of production in August (174,900 treatment courses), and 90 percent of production in September (232,800 treatment courses), in addition to an allocation for clinical trials. A treatment course of remdesivir is, on average, 6.25 vials.

Hospitals will receive the product shipped by AmerisourceBergen and will pay no more than Gilead’s Wholesale Acquisition Price (WAC), which amounts to approximately $3,200 per treatment course. Generally, patients do not pay directly for hospital-administered drugs like remdesivir; rather, for Medicare and most private insurers, the drug’s cost is incorporated into payments made by the insurer, such as Medicare paying for the drug through a diagnostic-related group.

These supplies will be allocated in the same way that Gilead’s donation of approximately 120,000 treatment courses of remdesivir were allocated: HHS allocates product to state and territorial health departments based on COVID-19 hospital burden, and health departments allocate it to hospitals. The delivery of the purchased remdesivir will be streamlined, going directly to the hospital, per the state’s allocation decision, rather than going first to the state health departments for subsequent delivery to hospitals.

Shipments will likely occur every two weeks, as they have with the donated product. The final allocation of Gilead’s approximately 120,000 donated treatment courses is being shipped today, June 29.

Anonymous wrote:1. Mortality rate for even the over-70 set is something like 20%--high, but far from 100%.

2. They got top-shelf, immediate medical care. Trump in particular was also likely being very closely monitored.

3. Treatments overall are much better now, as PPs have mentioned.